{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:37:26Z","timestamp":1784281046498,"version":"3.55.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Fondo Investigaci\u00f3n Sanitaria-ISCIII","award":["PI17\/00404"],"award-info":[{"award-number":["PI17\/00404"]}]},{"name":"Fondo Investigaci\u00f3n Sanitaria-ISCIII","award":["PI19\/01206"],"award-info":[{"award-number":["PI19\/01206"]}]},{"name":"Fondo Investigaci\u00f3n Sanitaria-ISCIII","award":["PI20\/00793"],"award-info":[{"award-number":["PI20\/00793"]}]},{"name":"Fondo Investigaci\u00f3n Sanitaria-ISCIII","award":["PI22\/01155"],"award-info":[{"award-number":["PI22\/01155"]}]},{"name":"Fondo Investigaci\u00f3n Sanitaria-ISCIII","award":["CIBER-CB06\/01\/0040"],"award-info":[{"award-number":["CIBER-CB06\/01\/0040"]}]},{"name":"Fondo Investigaci\u00f3n Sanitaria-ISCIII","award":["RICORS-REI RD21\/0002\/0009"],"award-info":[{"award-number":["RICORS-REI RD21\/0002\/0009"]}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Europe\u2019\/\u2018Investing","award":["ED431E 2018\/03"],"award-info":[{"award-number":["ED431E 2018\/03"]}]},{"name":"Europe\u2019\/\u2018Investing","award":["IN607A2021\/07"],"award-info":[{"award-number":["IN607A2021\/07"]}]},{"name":"Europe\u2019\/\u2018Investing","award":["IN607D2020\/10"],"award-info":[{"award-number":["IN607D2020\/10"]}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["IN606B-2016\/005"],"award-info":[{"award-number":["IN606B-2016\/005"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"publisher","award":["CD19\/00229"],"award-info":[{"award-number":["CD19\/00229"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The objective of this study was to discover autoantibodies to non-modified proteins associated with the presence\/absence of ACPAs in RA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The autoantibody repertoire of 80 ACPA-negative and 80 ACPA-positive RA subjects from the Swedish population-based Epidemiological Investigation of RA (EIRA) cohort was screened using a suspension bead array built on protein fragments earlier described as autoimmunity targets. Four autoantibodies positive in the initial screening were validated in another set of EIRA samples containing 317 ACPA-positive, 302 ACPA-negative and 372 age- and sex-matched controls. The relationship between the four autoantibodies and lung abnormalities on high-resolution CT (HRCT) was examined in 93 early-RA patients from the LURA cohort. Association between the autoantibodies, smoking and MHC class II alleles was assessed by logistic regression analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Anti-ANOS1 and anti-MURC IgG levels were associated with ACPA-positive status [odds ratio (OR)\u2009=\u20093.02; 95% CI 1.87\u20134.89; and OR\u2009=\u20091.86; 95% CI 1.16\u20132.97, respectively] and increased in ACPA-positive patients compared with controls. Anti-ANOS1 IgG was associated with smoking habit (OR\u2009=\u20092.11; 95% CI 1.22\u20133.69) and anti-MURC IgG with the presence of the MHC class II \u2018shared-epitope\u2019 genes (OR\u2009=\u20091.95; 95% CI 1.11\u20133.46). Anti-TSPYL4 IgG was associated with being ACPA negative (OR\u2009=\u20090.41; 95% CI 0.19\u20130.89). Anti-TSPYL4 IgG and anti-MAP2K6 IgG levels were increased in the ACPA-negative patients compared with controls. Presence of anti-MAP2K6 IgG and anti-TSPYL4 IgG correlated negatively with HRCT-defined lung abnormalities.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These four autoantibodies may be useful in diagnostics and in predicting clinical phenotypes of RA.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae007","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T02:57:32Z","timestamp":1704855452000},"page":"3106-3114","source":"Crossref","is-referenced-by-count":3,"title":["Identification of circulating autoantibodies to non-modified proteins associated with ACPA status in early rheumatoid arthritis"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9395-0598","authenticated-orcid":false,"given":"Luc\u00eda","family":"Lourido","sequence":"first","affiliation":[{"name":"Unidad de Prote\u00f3mica, Grupo de Investigaci\u00f3n de Reumatolog\u00eda (GIR), Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a (INIBIC), Complexo Hospitalario Universitario de A Coru\u00f1a (CHUAC), Sergas, Universidade da Coru\u00f1a (UDC) , A Coru\u00f1a,","place":["Espa\u00f1a"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2606-8180","authenticated-orcid":false,"given":"Vijay","family":"Joshua","sequence":"additional","affiliation":[{"name":"Division for Rheumatology, Department of Medicine, (Solna) Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Hansson","sequence":"additional","affiliation":[{"name":"Division for Rheumatology, Department of Medicine, (Solna) Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Sj\u00f6berg","sequence":"additional","affiliation":[{"name":"Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Pin","sequence":"additional","affiliation":[{"name":"Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ruiz-Romero","sequence":"additional","affiliation":[{"name":"Unidad de Prote\u00f3mica, Grupo de Investigaci\u00f3n de Reumatolog\u00eda (GIR), Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a (INIBIC), Complexo Hospitalario Universitario de A Coru\u00f1a (CHUAC), Sergas, Universidade da Coru\u00f1a (UDC) , A Coru\u00f1a,","place":["Espa\u00f1a"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Bioingenier\u00eda, Biomateriales y Nanomedicina (CIBER-BBN) , Madrid,","place":["Espa\u00f1a"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Alfredsson","sequence":"additional","affiliation":[{"name":"Institute of Environmental Medicine, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9601-6186","authenticated-orcid":false,"given":"Lars","family":"Klareskog","sequence":"additional","affiliation":[{"name":"Division for Rheumatology, Department of Medicine, (Solna) Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J","family":"Blanco","sequence":"additional","affiliation":[{"name":"Unidad de Prote\u00f3mica, Grupo de Investigaci\u00f3n de Reumatolog\u00eda (GIR), Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a (INIBIC), Complexo Hospitalario Universitario de A Coru\u00f1a (CHUAC), Sergas, Universidade da Coru\u00f1a (UDC) , A Coru\u00f1a,","place":["Espa\u00f1a"]},{"name":"Grupo de Investigaci\u00f3n en Reumatolog\u00eda y Salud (GIR-S), Centro Interdisciplinar de Qu\u00edmica e Biolox\u00eda (CICA), Departamento de Fisioterapia, Medicina y Ciencias Biom\u00e9dica, Facultad de Fisioterapia, Universidade da Coru\u00f1a (UDC) , A Coru\u00f1a,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,9]]},"reference":[{"key":"2024110419212819600_keae007-B1","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2024110419212819600_keae007-B2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s42358-018-0042-8","article-title":"Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis","volume":"59","author":"de Brito Rocha","year":"2019","journal-title":"Adv Rheumatol"},{"issue":"Suppl 6","key":"2024110419212819600_keae007-B3","doi-asserted-by":"crossref","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","article-title":"ACR\/EULAR 2010 rheumatoid arthritis classification criteria","volume":"51","author":"Kay","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2024110419212819600_keae007-B4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5114\/ceji.2017.72807","article-title":"The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis","volume":"42","author":"Kurowska","year":"2017","journal-title":"Cent Eur J Immunol"},{"key":"2024110419212819600_keae007-B5","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2024110419212819600_keae007-B6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nri.2016.124","article-title":"The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting","volume":"17","author":"Malmstr\u00f6m","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"2024110419212819600_keae007-B7","doi-asserted-by":"crossref","first-page":"102400","DOI":"10.1016\/j.jaut.2019.102400","article-title":"The etiology of rheumatoid arthritis","volume":"110","author":"Scherer","year":"2020","journal-title":"J Autoimmun"},{"key":"2024110419212819600_keae007-B8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/annrheumdis-2012-201456","article-title":"Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study","volume":"72","author":"Gremese","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2024110419212819600_keae007-B9","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.mayocp.2019.05.023","article-title":"Evidence of diagnostic and treatment delay in seronegative rheumatoid arthritis: missing the window of opportunity","volume":"94","author":"Coffey","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"2024110419212819600_keae007-B10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s13075-015-0860-6","article-title":"The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis","volume":"17","author":"Shi","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2024110419212819600_keae007-B11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/annrheumdis-2014-206785","article-title":"Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis","volume":"75","author":"Juarez","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2024110419212819600_keae007-B12","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024110419212819600_keae007-B13","doi-asserted-by":"crossref","first-page":"19263","DOI":"10.1038\/s41598-020-73919-y","article-title":"Improved classification of rheumatoid arthritis with a score including anti-acetylated ornithine antibodies","volume":"10","author":"Rodriguez-Mart\u00ednez","year":"2020","journal-title":"Sci Rep"},{"key":"2024110419212819600_keae007-B14","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1038\/s41598-023-32428-4","article-title":"Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity","volume":"13","author":"Cunningham","year":"2023","journal-title":"Sci Rep"},{"key":"2024110419212819600_keae007-B15","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/art.42463","article-title":"Autoantibodies to disease-related proteins in joints as novel biomarkers for the diagnosis of rheumatoid arthritis","volume":"75","author":"L\u00f6nnblom","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2024110419212819600_keae007-B16","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/rheumatology\/kew198","article-title":"Autoantibodies to two novel peptides in seronegative and early rheumatoid arthritis","volume":"55","author":"De Winter","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2024110419212819600_keae007-B17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41584-018-0070-0","article-title":"Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction","volume":"14","author":"Holers","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2024110419212819600_keae007-B18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2024110419212819600_keae007-B19","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1002\/art.23936","article-title":"Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase","volume":"58","author":"Lundberg","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2024110419212819600_keae007-B20","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/art.42549","article-title":"Rheumatoid arthritis specific autoimmunity in the lung before and at the onset of disease","volume":"75","author":"Joshua","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2024110419212819600_keae007-B21","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/art.41385","article-title":"Different Hierarchies of Anti-Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis","volume":"72","author":"Sahlstr\u00f6m","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2024110419212819600_keae007-B22","doi-asserted-by":"crossref","first-page":"M9.00384","DOI":"10.1074\/mcp.M9.00384","article-title":"Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays","volume":"11","author":"Wright","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"2024110419212819600_keae007-B23","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/ar3800","article-title":"Circulating and synovial antibody profiling of juvenile arthritis patients by nucleic acid programmable protein arrays","volume":"14","author":"Gibson","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2024110419212819600_keae007-B24","doi-asserted-by":"crossref","first-page":"e44824","DOI":"10.1371\/journal.pone.0044824","article-title":"Immune complex signatures of patients with active and inactive SLE revealed by multiplex protein binding analysis on antigen microarrays","volume":"7","author":"Papp","year":"2012","journal-title":"PLoS One"},{"key":"2024110419212819600_keae007-B25","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/ard.62.9.835","article-title":"Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases","volume":"62","author":"Stolt","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"2024110419212819600_keae007-B26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2024110419212819600_keae007-B27","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2024110419212819600_keae007-B28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/art.38201","article-title":"Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis","volume":"66","author":"Reynisdottir","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2024110419212819600_keae007-B29","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1074\/mcp.M500279-MCP200","article-title":"A human protein atlas for normal and cancer tissues based on antibody proteomics","volume":"4","author":"Uhl\u00e9n","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"2024110419212819600_keae007-B30","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1074\/mcp.M112.026757","article-title":"Autoantibody profiling in multiple sclerosis using arrays of human protein fragments","volume":"12","author":"Ayoglu","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"2024110419212819600_keae007-B31","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.semarthrit.2020.06.010","article-title":"Association of serum anti-centromere protein F antibodies with clinical response to infliximab in patients with rheumatoid arthritis: a prospective study","volume":"50","author":"Lourido","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2024110419212819600_keae007-B32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2024110419212819600_keae007-B33","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.4155\/bio.16.31","article-title":"Antigen arrays for profiling autoantibody repertoires","volume":"8","author":"Ayoglu","year":"2016","journal-title":"Bioanalysis"},{"key":"2024110419212819600_keae007-B34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/(SICI)1097-0177(199905)215:1<26::AID-DVDY4>3.0.CO;2-D","article-title":"Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: implications for the developmental anomalies of X chromosome-linked Kallmann syndrome","volume":"215","author":"Hardelin","year":"1999","journal-title":"Dev Dyn"},{"key":"2024110419212819600_keae007-B35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/bfgp\/elw037","article-title":"ANOS1: a unified nomenclature for Kallmann syndrome 1 gene (KAL1) and anosmin-1","volume":"16","author":"de Castro","year":"2017","journal-title":"Brief Funct Genomics"},{"key":"2024110419212819600_keae007-B36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/978-1-4614-8090-7_12","article-title":"The adhesion molecule anosmin-1 in neurology: kallmann syndrome and beyond","volume":"8","author":"de Castro","year":"2014","journal-title":"Adv Neurobiol"},{"key":"2024110419212819600_keae007-B37","doi-asserted-by":"crossref","first-page":"14899","DOI":"10.1523\/JNEUROSCI.1158-11.2011","article-title":"FGF-2 and Anosmin-1 are selectively expressed in different types of multiple sclerosis lesions","volume":"31","author":"Clemente","year":"2011","journal-title":"J Neurosci"},{"key":"2024110419212819600_keae007-B38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/ERC-13-0181","article-title":"Anosmin-1 contributes to brain tumor malignancy through integrin signal pathways","volume":"21","author":"Choy","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"2024110419212819600_keae007-B39","doi-asserted-by":"crossref","first-page":"110417","DOI":"10.1016\/j.cellsig.2022.110417","article-title":"Anosmin 1 N-terminal domains modulate prokineticin receptor 2 activation by prokineticin 2","volume":"98","author":"Murcia-Belmonte","year":"2022","journal-title":"Cell Signal"},{"key":"2024110419212819600_keae007-B40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/ard.2010.143529","article-title":"Selective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis (1987 ACR criteria compared to 2010 ACR\/EULAR criteria): a prospective study aimed at identification of diagnostic and prognostic biomarkers as well as therapeutic targets","volume":"71","author":"de Launay","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2024110419212819600_keae007-B41","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/ard.2009.112201","article-title":"Kinetic analysis of synovial signalling and gene expression in animal models of arthritis","volume":"69","author":"Fukushima","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2024110419212819600_keae007-B42","doi-asserted-by":"crossref","first-page":"H2127","DOI":"10.1152\/ajpheart.00446.2015","article-title":"The coiled-coil domain of MURC\/cavin-4 is involved in membrane trafficking of caveolin-3 in cardiomyocytes","volume":"309","author":"Naito","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024110419212819600_keae007-B43","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1073\/pnas.1315359111","article-title":"MURC\/Cavin-4 facilitates recruitment of ERK to caveolae and concentric cardiac hypertrophy induced by \u03b11-adrenergic receptors","volume":"111","author":"Ogata","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024110419212819600_keae007-B44","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1128\/MCB.02186-07","article-title":"MURC, a muscle-restricted coiled-coil protein that modulates the Rho\/ROCK pathway, induces cardiac dysfunction and conduction disturbance","volume":"28","author":"Ogata","year":"2008","journal-title":"Mol Cell Biol"},{"key":"2024110419212819600_keae007-B45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCGENETICS.111.959866","article-title":"Molecular genetic and functional characterization implicate muscle-restricted coiled-coil gene (MURC) as a causal gene for familial dilated cardiomyopathy","volume":"4","author":"Rodriguez","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"2024110419212819600_keae007-B46","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/art.33359","article-title":"Decreased collagen-induced arthritis severity and adaptive immunity in MKK-6-deficient mice","volume":"64","author":"Hammaker","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2024110419212819600_keae007-B47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0002-9440(10)63108-2","article-title":"Expression and activation of mitogen-activated protein kinase kinases-3 and -6 in rheumatoid arthritis","volume":"164","author":"Chabaud-Riou","year":"2004","journal-title":"Am J Pathol"},{"key":"2024110419212819600_keae007-B48","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.4049\/jimmunol.174.7.4301","article-title":"Regulation of p38 MAPK by MAPK kinases 3 and 6 in fibroblast-like synoviocytes","volume":"174","author":"Inoue","year":"2005","journal-title":"J Immunol"},{"key":"2024110419212819600_keae007-B49","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.4049\/jimmunol.0900483","article-title":"Role of MAPK kinase 6 in arthritis: distinct mechanism of action in inflammation and cytokine expression","volume":"183","author":"Yoshizawa","year":"2009","journal-title":"J Immunol"},{"key":"2024110419212819600_keae007-B50","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3892\/mmr.2012.964","article-title":"Single-nucleotide polymorphisms in the TSPYL-4 and NT5DC1 genes are associated with susceptibility to chronic obstructive pulmonary disease","volume":"6","author":"Guo","year":"2012","journal-title":"Mol Med Rep"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae007\/56543555\/keae007.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/11\/3106\/60415448\/keae007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/11\/3106\/60415448\/keae007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T19:21:47Z","timestamp":1730748107000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/11\/3106\/7513696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,9]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,1,9]]},"published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae007","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,1,9]]}}}